Our Leadership

Neurxstem is guided by a multidisciplinary team spanning neuroscience, genomics, clinical medicine, AI, pharmacology, regulatory science, finance, strategy, and patient advocacy anchored by the stewardship of the world’s oldest surviving family trust.

Executive Leadership

Dr. Rene Anand

Chief Executive Officer & Founder
MS (Chemical & Quantum Physics), PhD (Genomics), PD Fellow (Neuroscience)
Technology Inventor

Lord Mark Reardon

Chairman & President, Sully Trust & Foundation (Monaco)

Steward of the world’s oldest surviving family trust, originating in the Knights Templar era and carried through a 1,000-year House of Béthune lineage, with a history of advancing major cultural and scientific projects globally

Dr. Peter Cruse

Chief Medical Officer
MBChB, PhD, FRCPath, FFPath, MBA
Fellow, Royal Society of Medicine, London

Scientific Leadership & Medical Consultants

Dr. Alexandre Kouriatov

Pharmacology, Neuroscience & Stem Cell Biology

Dr. Manoj Samanta, PhD

AI Health, Computational Biology, Electrical & Nuclear Engineering
NASA Ames Research Center, Hewlett-Packard

Dr. Clay Marsh, MD

Vice President & Executive Dean
Virginia University Health Sciences

Dr. Joseph D. Armstrong III, PhD

Former Chief Operating Officer, Merck
Global Head of Business Development, TCG GreenChem

Susan McKay, MS

Immunology, Technology Co-Inventor

Dr. Louis DeLuca, MD

Cosmetic, Aesthetic & Anti-Aging Medicine

Business Advisors

Carina Cunha

Strategy & Commercialization
FORUS, Castle, Y42, Former JPMorgan, Accenture Strategy, Founders Intelligence, Crimson Education
Columbia University & University of Edinburgh